Skip to content
Screener

Net margin at other companies

Crinetics Pharmaceuticals logo
Crinetics PharmaceuticalsCRNX
-2,747.2%-1,328pp
uniQure logo
uniQureQURE
-1,350.7%-35.3pp
MeiraGTx Holdings plc logo
MeiraGTx Holdings plcMGTX
-615.3%
AdaptHealth logo
AdaptHealthAHCO
-2.4%-5.1pp
CalAmp logo
CalAmpCAMP
-2,193.7%-581pp

Other financials

Income statement

See full
Revenue-
Gross profit-
Operating income-$45.7M-6.6%
Net income-$43.4M-4.8%
EPS (diluted)-$0.39+15.2%

Balance sheet

See full
Cash & equivalents$49.3M-15.1%
Total debt$5.3M-11.9%
Total equity$239.2M+42.5%
Total assets$264.6M+36.0%

Cash flow

See full
Operating cash flow-$31.4M-24.5%
CapEx$86.0K+330%
Free cash flow-$28.0M+52.6%

Valuation

See full
Market cap$2.7B+269%
Enterprise value$2.65B+291%

Profitability

See full
Gross margin100%+6.9pp
Operating margin-47,349.8%-47,409pp
FCF margin-39,826.7%-39,847pp

Returns & leverage

See full
Return on equity-74.7%-9.5pp
Debt / equity0.0×
Current ratio12.1×+3.4×

Where this comes from

Calculated from Amylyx Pharmaceuticals, Inc.’s reported figures.

Based on trailing twelve months.

The source filing: Amylyx Pharmaceuticals, Inc.’s 10-Q, filed August 6, 2026. Open the filing →

Filed
Aug 6, 2026, 7:04 AM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001193125-26-336682

FAQ

What is Amylyx Pharmaceuticals, Inc.'s net margin?
Amylyx Pharmaceuticals, Inc. (AMLX) reported net margin of -45,096.2% in Q2 2025.
How has Amylyx Pharmaceuticals, Inc.'s net margin changed year-over-year?
Amylyx Pharmaceuticals, Inc.'s net margin decreased by 81126.8% year-over-year, from -55.5% to -45,096.2%.
What does net margin mean?
Net income as a percentage of revenue (trailing twelve months). The bottom-line profitability measure after all costs, interest, and taxes.

Ask your AI about Amylyx Pharmaceuticals, Inc.'s net margin.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude